Physician profile
Nathan E Hale
NPI 1861719650
$6,868.04
in general payments reported to CMS, 2019-2025
33 companies · $789 in 2025
The $789 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $165 · 2021: $284 · 2022: $798 · 2023: $238 · 2024: $4,313 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,314 · Education: $1,500 · Travel and Lodging: $1,341 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,314.10 |
| Education | $1,500.00 |
| Travel and Lodging | $1,341.13 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $184.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,291.47 | 2019-2025 | |
| Boston Scientific Corporation | $922.40 | 2020-2024 | Ams 700, Lithovue |
| Janssen Scientific Affairs, LLC | $278.57 | 2024-2025 | Erleada |
| Astellas Pharma US INC | $255.44 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $247.75 | 2023-2025 | Orgovyx |
| Urogen Pharma, INC. | $215.97 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $174.74 | 2023-2025 | Prolaris |
| Myovant Sciences INC. | $165.08 | 2021-2022 | |
| Pfizer INC. | $153.95 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $138.81 | 2024-2025 | Welireg, Keytruda, Lynparza |
| Axonics, INC. | $138.37 | 2023-2024 | Axonics |
| Bioprotect Medical, INC. | $88.29 | 2025 | Bioprotect Balloon Implant System |
| Neotract INC. | $77.78 | 2020 | |
| Richard Wolf Medical Instruments Corp. | $73.70 | 2022 | |
| Ethicon US, LLC | $72.51 | 2022-2023 | Prolene |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $58.57 | 2025 | |
| Janssen Biotech, INC. | $57.35 | 2022 | |
| Dendreon Pharmaceuticals LLC | $56.96 | 2024-2025 | Provenge |
| Abbvie INC. | $52.91 | 2021-2025 | |
| Olympus America INC. | $52.62 | 2025 | Itind System |
| Blue Earth Diagnostics | $48.48 | 2022 | |
| Laborie Medical Technologies Corp. | $31.78 | 2025 | |
| Novartis Pharmaceuticals Corporation | $26.66 | 2025 | |
| Halozyme INC | $26.34 | 2023 | |
| Ambu INC. | $21.99 | 2022 | |
| Travere Therapeutics, INC. | $21.40 | 2019 | |
| Endo Pharmaceuticals INC. | $20.41 | 2023 | Xiaflex |
| Procept Biorobotics Corporation | $19.83 | 2025 | |
| Innocoll Pharmaceuticals Limited | $18.94 | 2022 | |
| Edap Technomed INC | $16.03 | 2025 | |
| Photocure INC | $15.31 | 2024 | Cysview |
| Urovant Sciences INC | $14.50 | 2022 | |
| Ferring Pharmaceuticals INC. | $13.13 | 2024 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Hale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.